FDA Investigator Dana M Klimavicz

Dana M Klimavicz has conducted inspections on 341 sites in 7 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
341
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100005798
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Canada, Netherlands, Brazil, Germany, France
FDA Investigators that have inspected at least one site in common with Dana M Klimavicz:
Abby Lmozeke Baker, Alan P Kurtzberg, Alexis O Robinson, Allen F Hall, Althea A Williams, Amanda K Willey, Amy A Johnson, Andre L Duhon, Ann B Borromeo, Anthony J Grace, Armando Chavez, MS, Barbara D Wright, Barbara Janine Breithaupt, Barbara S Manson, Bonita S Chester, Bonnie E Conley, Bonnie E Pierson, Brian S Lynch, Carla A Norris, Carmen M Chan, Carol S Sanchez, Carolyn E Barney, Charles M Edwards, Charles N Dupont, Christie B Rice, Christophe L Boulmay, Christopher J Adams, Christopher M Jeffers, Claire M Minden, Claude L Brunson, Claudele S Razo, Clifton C Francis, Cody D Rickman, Combs, Cynthia L Medlin, Cynthia R Crocker, Cynthia R Gibson, Dana M Daigle, Danielle M Maddox, Daphne A Videau, David J Leray, Dawn P Hall, Deborah A Greco, Diana M Guidry, Diane Hall, Dolores E Price, Dolores Harper, Donna D Gallien, MPH, Dr. Koffi A Amegadje, Dr. Sriram Subramaniam, PhD, Eddie J Rigsby, Edward A Brunt, Edwin Martinez, Elizabeth D Battles, Elizabeth D Connell, Emily E Smith, Eric S Weilage, Erica M Katherine, Erika M Wilkerson, Esra Toussaint, Fabian Nchaparro Rodriguez, Francis A Guidry, Gene R Gunn, Gloria A Milster, Henry E Sanchez, Herbert M Corbello, Herman S Clincy, Iris C Macinnes, Jacqueline A O'shaughnessy, PhD, James M Kewley, James W Blakely, Jason D Abel, Javelle P Spann, Jeffrey P Raimondi, Jerry T Hunt, John A Iwen, Johnathan M Crayton, Joseph B Carballa, Juanelma H Palmer, Karen R Smallwood, Kari L Batey, Kellie R Riggs, Kena M Senegal, Kenneth L Smalls, Kenneth R Merritt, Kip J Hanks, Konsuela Y Glass, Lacey J Chessor, Lakisha N Morton, Laressa R Gray, Larry A Estavan, Laura E Garcia, Laura L Staples, Leisha R Shipes, Leon L Crawley, Lisa P Oakes, Llopis, M A Abel I, Mahaffey, Marcus L Head, Mark W Rivero, Marla A Cassidy, Marlene L Davis, Martin K Yau, PhD, Marvin D Jones, Mary A Millner, Mary I Surratt, Matthew R Coleman, Michael F Skelly, PhD, Michael W Roosevelt, Muralidhara B Gavini, PhD, Myla D Chapman, Natalie A Guidry, Natasha N Mccants, Nicole M Bell, Nikki S Bryant, Nilufer M Tampal, PhD, Nimmy Mathews, Patricia S Smith, Patrick C Dooley, Randy D Baxter, Randy L Clarida, Raymond T Oji, Rebecca Rodriguez, Samantha J Bradley, Sarah Forney, Scott A Watson, Scott B Laufenberg, Shelton L Stribling, Sheri S Oliver, Shirhonda D Thorn, Shirley H Isbill, Shusheen A Alexander, Shymetris M Allen, Sidney M Smith, Stacy G Marshall, Stacy M Below, Stephanie A Cochran, Stephanie E Hubbard, Susan F Laska, MS, Teresa Y Bills, Thomas O Morgan, Thomas R Stanley, Tiana M Mckinley, Timothy P Lafave, Toni M Booker, Traci M Armand, Travis E Chapman, Truong Xuan Nguyen (Andy), Vanessa E Coulter, Verlinda A Narcisse, Victoria V Bot, Wanda B Coats, Wayne S Fortenberry, Wendy R Blame, William D Bassett, Jr

Dana M Klimavicz's Documents

Publish Date Document Type Title
April, 2015 EIR Louisiana IVF Laboratries LLC. - EIR, 2015-04-09
February, 2003 FDA 483 Lake Charles Memorial Hospital IRB - Form 483, 2003-02-06
June, 2014 EIR David Christopher Black, M.D. - EIR, 2014-06-18
November, 2001 FDA 483 Ochsner Clinic Foundation IRB - Form 483, 2001-11-28
November, 2008 FDA 483 Francisco J Candal, MD - Form 483, 2008-11-14
October, 2016 EIR Cytocentrics, Inc. - EIR, 2016-10-26
April, 2002 FDA 483 Brown, MD, Nate - Form 483, 2002-04-12
October, 2011 FDA 483 Kashinath G Yadalam M D - Form 483, 2011-10-06
October, 2014 EIR East Jefferson General Hospital IRB - EIR, 2014-10-01
January, 2008 FDA 483 Owen Biosciences Inc - Form 483, 2008-01-07
September, 2006 FDA 483 Response Robert Michael Murray, MD - Form 483R, 2006-10-16
March, 2001 EIR Dickey, Richard R, Dr. - EIR, 2001-03-09
February, 2014 EIR Jonathan K. Wise, M.D. - EIR, 2014-02-05
October, 2011 EIR Kashinath G Yadalam M D - EIR, 2011-10-06
October, 2011 FDA 483 Response Kashinath G Yadalam M D - Form 483R, 2011-10-18
March, 2011 FDA 483 Gabriel Perez Lasala, MD - Form 483, 2011-03-31
April, 2002 EIR Brown, MD, Nate - EIR, 2002-04-12
March, 2013 FDA 483 Joseph A. Kwentus, M.D. - Form 483, 2013-03-18
June, 2014 FDA 483 David Christopher Black, M.D. - Form 483, 2014-06-18
April, 2001 FDA 483 LaHaye, Leon C., M.D. - Form 483, 2001-04-19
December, 2017 FDA 483 Jonathan K. Wise, M.D. - Form 483, 2017-12-13
September, 2006 EIR Robert Michael Murray, MD - EIR, 2006-09-14
August, 2001 FDA 483 Response Palazzo, Maria Carmen, MD, PhD - Form 483R, 2001-11-19
November, 2014 EIR Biomat USA, Inc. - EIR, 2014-11-07
September, 2006 FDA 483 Robert Michael Murray, MD - Form 483, 2006-09-14
November, 2011 FDA 483 David R. Spigel, M.D. - Form 483, 2011-11-02
February, 2010 FDA 483 Pennington Biomedical Research Center IRB - Form 483, 2010-02-01
November, 2000 FDA 483 Ochsner Clinic Foundation IRB - Form 483, 2000-11-28
June, 2001 EIR DeBoisblanc, Bennett P., M. D. - EIR, 2001-06-27
October, 2014 FDA 483 Response East Jefferson General Hospital IRB - Form 483R, 2014-10-08
August, 2018 FDA 483 Wayne J.G. Hellstrom, M.D. - Form 483, 2018-08-23
August, 2018 EIR Wayne J.G. Hellstrom, M.D. - EIR, 2018-08-23
October, 2014 FDA 483 East Jefferson General Hospital IRB - Form 483, 2014-10-01
June, 2000 FDA 483 Response Mathew, Chavaramplakil P., M.D. - Form 483R, 2000-07-20
March, 2013 EIR Joseph A. Kwentus, M.D. - EIR, 2013-03-18
April, 2001 FDA 483 Response LaHaye, Leon C., M.D. - Form 483R, 2001-08-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more